Recent results of immunotherapy and perspectives for advanced NSCLC

In this commentary from Lung Cancer Management, learn more about immunotherapy and non-small-cell lung carcinoma.

Go to the profile of RegMedNet
Jul 31, 2018
0
0
Upvote 0 Comment

It is estimated that 224,390 new cases of lung cancer will be diagnosed in 2016 in USA, making it the second most incident cancer for all genders, only behind breast cancer. Additionally, lung cancer will be first cause of cancer death in USA during this year, causing 150,080 estimated deaths. In this commentary, published in Lung Cancer Management, Denis L Jardim and Debora de Melo Gagliato discuss recent results of immunotherapy for the indication of non-small-cell lung carcinoma.

Access the paper through

Jardim DL, de Melo Gagliato D. Recent results of immunotherapy and perspectives for advanced NSCLC. Lung Cancer Manag. 5(2), 57–60 (2016)

Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.